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Introduction
Metabolic Syndrome is becoming a more prevalent health issue within the United States,
currently affecting 22% of adults (Capuron et al., 2008). Several factors contribute to the
diagnosis of Metabolic Syndrome, including obesity, high levels of triglycerides, elevated blood
pressure, and low high-density lipoprotein cholesterol. Metabolic Syndrome puts those who have
it at an increased risk for numerous diseases, such as type 2 diabetes, cardiovascular disease, and
cancer (Jennings et al., 2007).
Several studies have shown that Metabolic Syndrome plays a negative role in sleep and
mood of those with the disease. Individuals with Metabolic Syndrome often have poor sleep
quality, which could contribute to worsening of the risk factors associated with the disease
(Hung et. al 2013). Metabolic Syndrome has also been linked to obstructive sleep apnea and is
prevalent in those with the disease (Parish et al., 2007). There is also evidence that short sleep
duration and poor sleep quality are associated with obesity, one of the risk factors for Metabolic
Syndrome (Jennings et al., 2007).
Individuals with Metabolic Syndrome are more susceptible to symptoms of certain
psychological disorders, such as depression (Capuron et al, 2008). An additional study has
shown that out of the patients diagnosed with bipolar disorder, 49% of them were obese, which is
an indicator of Metabolic Syndrome. The same study also showed that the factors of Metabolic
Syndrome negatively impacted the patient’s emotional well-being, physical health, quality of
life, and self-esteem (Fagiolini et al., 2005).
One method that has been shown to help those with Metabolic Syndrome has been higher
protein diets. Higher protein diets have been shown to improve markers of Metabolic Syndrome
by reducing fasting blood glycose levels, improving post meal insulin response, and reducing
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cholesterol levels (Layman & Baum, 2005). In addition, higher protein diets increase weight loss
in those with metabolic syndrome, which in turn improves their sleep duration and sleep quality
(Zhou et al., 2016). Research also shows that those with high protein diets experience less sleep
disorders, such as insomnia, than those with low protein diets (Jennings et al., 2007).
The objective of this study is to determine the role of higher protein diets on the
regulation of mood and sleep in patients with Metabolic Syndrome. The hypothesis for the study
is that a higher protein diet will create a better quality of sleep for the individuals and lengthen
their sleep duration, as well as create an increase in the emotional well-being of the individuals
through increased weight loss and improved regulation of blood glucose control.

Materials and Methods
Participant Recruitment and Consent. A total of eleven participants (male and female,
18+ years) with Metabolic Syndrome (characterized by participant having three or more of the
following measurements: abdominal obesity, triglyceride level over 150 mg/dl, HDL cholesterol
< 40 mg/dl in men and 50 mg/dl in women, systolic blood pressure of 130 mm Hg or diastolic
blood pressure of 85 mm Hg, and/or fasting glucose > 100 mg/dL) were recruited to participate
in the study. Participants also had to be consuming a lower protein diet (less than 20% of total
calorie intake) before enrolling in the study. Ethical approval for the study was obtained from the
Institutional Review Board at the University of Arkansas. Written consent was obtained from all
individuals who participated in the study.
There were three phases of the recruitment plan. In Phase 1 of the recruitment, we
advertised for participants using the University digital newspaper, which is distributed to all
faculty, staff, and students on a daily basis. We advertised on the Center for Human Nutrition
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website and with the local newspaper and public radio station. We also advertised using flyers
within the Food Science Department. Finally, we used social media (E.g., Facebook, Twitter,
and Instagram) and relied on word-of-mouth. Phase 2 of recruitment involved a phone screening.
All information will be kept confidential. Individuals who had food allergies, diet restrictions,
recently dieted (past 3 months), were taking medication that could impact cholesterol or glucose
metabolism, or had any other diet-related conditions that would prevent them from consuming a
high protein diet, were excluded from the study. In addition, individuals who used illicit drugs or
abuse alcohol, were pregnant or breastfeeding were also excluded from the study at the time.
Phase 3 was the final stage of recruitment, which was an in-person screening. Height and weight
and baseline cardiometabolic markers were confirmed at this time using a Cholestech LDX
Analyzer (Columbus, OH). The consent forms were also explained and signed at this time.
Study Design. The participants (n=11) were assigned to a dietary treatment that consisted
of a higher protein diet with >30% of calories coming from protein. At the beginning of the
study, the participants were informed of different foods and meals that would fit within the high
protein diet. They were given different tools to allow them to follow the diet easier, such as
measuring cups and recipes. Each participant followed the high protein diet for 28 days, and then
came back in for measurements and surveys. The study lasted a total of 16 weeks.
Anthropometrics: Measurements were taken on a monthly basis, which was every 4
weeks. Body height was measured to the nearest 0.1 cm using a stadiometer (Detecto, St. Louis,
MO) with subjects barefoot, in the free-standing position. Body weight was measured in the
fasting state with subjects without shoes to the nearest 0.05 kg using calibrated balance scales
(Detecto, St. Louis, MO). Body mass index (BMI) was calculated as weight (kg) divided by
height (m) squared. Body composition was measured at the beginning of the intervention using
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dual x-ray absorptiometry (DEXA), which was to control the energy expenditure measurements
to kg of lean mass. Waist-hip ratio (WHR) was calculated by measuring the circumference of the
waist (cm) and dividing it by the circumference of the hips (cm).
Assessment of Sleep and Well-being: At the beginning of every 4-week cycle,
mood/emotions, sleep, and physical activity were assessed. Sleep was assessed using the
Pittsburg Sleep Quality Index (PSQI) and by using an Actigraph monitor to track sleep in realtime. The PSQI involved a questionnaire, and it assessed the overall quality of sleep of the
participants. Questions on the questionnaire related to various aspects of sleep, such as sleep
efficiency and use of sleeping medication. The Actigraph monitors were issued to each
participant, and they tracked the duration of real-time sleep. Mood and emotions were assessed
using Profile of Mood States (POMS) questionnaires. POMS assesses six main mood states,
which includes tension, depression, anger, vigor, fatigue, and confusion.
Results
Participant Characteristics
The study consisted of a total of eleven participants. Table 1 shows the participant
characteristics, which includes age, sex, weight, height, BMI, WHR, fat mass, and ethnicity.
These measurements were taken at the beginning of the study at baseline.
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Table 1. Participant Characteristics, n = 11
Age (yr)
Sex:
Male
Female
Anthropometrics: Baseline
Weight, (kg)
Height, (cm)
BMI, (kg/m2)
WHR, (WHR)
Fat Mass, (%)
Ethnicity:
Caucasian
Hispanic
Asian
African American

38.2± 10.9
2
9
91.6 ± 17.0
162.2 ± 7.8
34.6 ± 5.1
0.92 ± 0.06
46.7 ± 4.5
8
1
1
1

Anthropometrics
Weight, Body Mass Index, Waist-Hip Ratio
Table 2 shows the average measurements for all of the participants that were recorded
throughout the 16-week study. The mean bodyweights of the participants did change over 16
weeks; however, there was not a significant decrease or increase in weight throughout the study
(P > 0.05). There was not a significant change in the mean BMI measurements throughout the
study (P >0.05). The figure also includes the mean WHR measurements of the participants, in
which there was not a significant change over 16 weeks (P >0.05).
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Table 2
Weight, (kg)
BMI, (kg/m2)
WHR, (W/H)

Baseline
91.6 ± 17.0
34.6 ± 5.1
0.92 ± 0.06

Week 4
90.8 ± 16.6
34.3 ± 4.8
0.91 ± 0.06

Week 8
90.7 ± 17.0
34.2 ± 4.9
0.91 ± 0.06

Week 12
90.8 ± 17.0
34.3 ± 5.0
0.91 ± 0.06

Week 16
91.1 ± 17.1
34.4 ± 5.0
0.90 ±0.06

Table 2. The results from the measurements for mean weight (kg), mean BMI (kg/m2), and mean
WHR (W/H). There was not a significant change in weight throughout the study (P >0.05). Since
there was not a significant weight change, that lead to there not being a significant change in
BMI or WHR throughout the 16 weeks (P >0.05).

Assessment of Sleep and Well-being
Pittsburgh Sleep Quality Index (PSQI)
Figure 1 displays the mean results with standard deviation from the PSQI global scores.
The mean score represents the quality of sleep overall that the participants were experiencing
throughout the study. The results show that there was a significant decrease in the mean global
scores (P <0.05). A higher mean score would indicate that the participants were experiencing an
overall poor sleep quality; therefore, since there was a significant decrease, the overall sleep
quality of the participants improved.
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Figure 1

PSQI Global Score
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Figure 1. The mean values with standard deviation for the Pittsburg Sleep Quality Index global
scores at each 4-week interval for a total of 16 weeks. The graph shows a significant decrease in
the mean PSQI global scores, with the baseline week being the highest score and Week 16 being
the lowest score (P<0.05).
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Profile of Mood States (POMS)
Figure 2 displays the mean results from the Total Mood Disturbance Scores with
standard deviation of the participants throughout the 16-week study. The POMS questionnaire
was administered to each participant at the beginning of every 4-week cycle. The questionnaire
asks questions about six mood states which includes Tension, Depression, Anger, Vigor, Fatigue,
and Confusion. The total score takes into account all of the mood states. The equation used for
the total mood disturbance scores is summing all of the mood states and then subtracting vigor.
Figure 2 shows that although there was a decrease in the mean total mood disturbance score
throughout the study, there was not a significant decrease (P >0.05). Figure 3a shows the mean
results from the mood state Tension scores with standard deviation. There was a significant
decrease in the mood state tension throughout the study, which would indicate that the
participants moods improved in regard to feelings of tension (P <0.05). The mood state
Depression is shown in Figure 3b. There was not a significant decrease or increase in the mood
state depression (P >0.05). Figure 4a shows the mean results for the mood state anger with
standard deviation. The results indicated that there was not a significant increase or decrease in
the mood state anger throughout the study (P >0.05). The mean results with standard deviation
for the mood state fatigue are shown in Figure 4b. The results showed that there was not a
significant change in the mean scores for the mood state fatigue during the study (P >0.05).
Figure 5a portrays the mean results with standard deviation for the scorings of the mood state
confusion. The results showed that there was not a significant change in the mood state
confusion (P >0.05). The mood state vigor is shown in Figure 5b. The results show that there
was not a significant change in the mood state vigor throughout the study (P >0.05). Overall, the
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only significant change in regard to the profile of mood states was the mean results for the mood
state tension.

Total Mood Disturbance Score

Figure 2
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Figure 2. The mean total mood disturbance scores with standard deviation taken at each 4-week
time interval for a total of 16 weeks. Although the graph shows that the baseline week score was
higher than the Week 16 score, there was not a significant decrease in the score throughout the
study.
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Figure 3b
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Figure 3. Mean mood states scores with standard deviation at each 4-week interval for a total of
16 weeks. Figure 3a shows a significant decrease in tension throughout the study (P<0.05).
Figure 3b shows a decrease in depression throughout the study, but the decrease was not
significant.
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Figure 4a
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Figure 4b

POMS, Fatigue

20
15
10
5
0
0

4

8

12

16

Time, weeks

Figure 4. Mean mood states scores with standard deviation at each 4-week interval for a total of
16 weeks. Figure 4a shows a decrease in anger throughout the study, but the decrease was not
significant. Figure 4b shows a decrease in fatigue, but the decrease was not significant.
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Figure 5a
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Figure 5b
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Figure 5. Mean mood states scores with standard deviation at each 4-week interval for a total of
16 weeks. Although Figure 5a shows a decrease in confusion throughout the study, the decrease
was not significant. Figure 5b shows that the decrease in vigor was not significant.
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Discussion
Results from this study show that consuming a higher protein diet may improve sleep
quality and better emotional well-being in regard to feelings of tension, which supports our
hypothesis. These findings suggest that individuals with metabolic syndrome can improve their
sleep quality and feel less tense by consuming a diet higher in protein.
The results from the study showed that the body weight of the participants did not
significantly change throughout the study. Since the body weights of the individuals did not change
significantly, there was also no significant change in BMI or WHR. Results from other literature
show that a decrease in weight leads to better sleep quality and changes in mood (Alfaris et al.,
2015). A study that included women who were in the early stages of metabolic syndrome and type
2 diabetes showed that a high protein diet led to weight loss, which opposed our findings (Te
Morenga et al., 2011). Another study that included participants with metabolic syndrome showed
that a high protein diet leads to a reduction in WHR, which also opposes the results from our study
(Campos-Nonato et al, 2017). It is possible that if the individuals in our study had a decrease in
weight, that it could contribute to a further improvement in quality of sleep and emotional wellbeing.
Data showed that there was a significant decrease in the PSQI global score throughout the
study. One study, that also involved the PSQI, showed that those who with metabolic syndrome
reported poor sleep quality and had high PSQI scores, which agree with the findings in this study
(Okubo et al., 2014). The PSQI scale takes into account an individual’s sleep quality, sleep latency,
sleep duration, sleep efficiency, sleep disturbance, use of medication, and daytime dysfunction
(Buysse et al., 1988). A decrease in the scoring indicates that the overall sleep quality of the
participants improved. These findings suggest that a higher protein diet is correlated with better
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sleep quality in patients with metabolic syndrome. This study correlates with other current
literature, which suggest that a high protein diet can lead to longer sleep duration and a better
quality of sleep in individuals who are obese, which is a factor of metabolic syndrome (Willi et
al., 1998). Another study showed that in increase in protein intake can lengthen the sleep duration
of individuals, which also supports the findings in our study (Grandner et al., 2013). Current
literature, along with this study, suggests that a diet high protein can lead to an overall better quality
of sleep.
In regard to mood, the results from the POMS questionnaire showed that overall, there was
no significant change in mood states. The POMS questionnaire looks at six mood states that are
identifiable and can be measured, which includes tension, depression, anger, vigor, fatigue, and
confusion. The only significant change was the mood state tension, which showed to decrease
throughout the study. Tension encompasses multiple feelings, such as anxiety, worry, and being
on edge. This data correlates with current studies that also used the POMS questionnaire to
evaluate the moods of the participants. These studies also found that the emotional well-being of
obese adults improved after consuming a high protein diet (Breymeyer et al., 2016). Another study
that involved participants who were obese and had type 2 diabetes, which are both factors of
metabolic syndrome, also showed an increase in emotional well-being after consuming a high
protein diet (Watson et al., 2018). In contrast, one study showed that after consuming a highprotein meal, the moods of the participants did not improve (Lemmens et al., 2011). The findings
in our study suggest that a higher protein diet may improve the mood state tension, but more data
is needed to show a correlation between a high protein diet and an overall increase in emotional
well-being in patients with metabolic syndrome.

17

Even though the results supported the hypothesis that a higher protein diet creates better
sleep quality and improves emotional well-being in individuals with metabolic syndrome, the
study still had limitations. One of the main limitations of the study was that there were only eleven
participants. Since there were certain parameters that the participants had to meet, it was difficult
to find individuals that qualified. If the study implemented more recruitment and had another cycle
of participants, then the number of individuals could have possibly increased. More data on a larger
number of participants would help to strengthen the conclusions of the results. Additionally,
further research could be done on participants without metabolic syndrome to see if higher protein
diets still play a role in the regulation of mood and sleep. This study focused on individuals with
metabolic syndrome specifically; therefore, it cannot be concluded that a high protein diet
improves sleep and emotional well-being in those without metabolic syndrome.
As metabolic syndrome continues to increase throughout the world, it is important for
individuals to maintain healthy diets and lifestyle practices. With those who have metabolic
syndrome, it is suggested that changing to a high protein diet can lead to better physical and mental
health. According to this study, consuming a high protein diet leads to a better quality of sleep and
can even improve emotional well-being in regard to tension in those with metabolic syndrome.
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